EDAP TMS SA shared interim results on July 19, 2024, from its Phase 3 study on robotic HIFU therapy for treating endometriosis. The therapy shows good safety but did not meet its primary pain reduction goal at three months, despite notable improvements in other symptoms and ongoing study progression.